当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3732469
已选条件
-
T67776PCSK9-IN-11PCSK9IN11
PCSK9-IN-11 (compound 5r) is a potent PCSK9 inhibitor with oral activity. PCSK9-IN-11 shows inhibitory activity of PCSK9 transcription in HepG2 cells (IC50= 5.7 μM). PCSK9-IN-11 can increase LDL receptor (LDLR) protein level. PCSK9-IN-11 can be used for atherosclerosis research.
价 格:¥电议型 号:T67776产 地:中国大陆
-
T81535PCSK9-IN-20;化合物 PCSK9-IN-20PCSK9-IN-20
PCSK9-IN-20 (Compound 3i) is a PCSK9 inhibitor exhibiting an IC50 value of 3.96 ?M, shown to reduce PCSK9 and enhance LDLR protein levels in vitro [1].
价 格:¥电议型 号:T81535产 地:中国大陆
-
T79239PCSK9-IN-19;化合物 PCSK9-IN-19PCSK9-IN-19
PCSK9-IN-19 (Compound 1), a PCSK9 inhibitor, is utilized in researching the treatment of high LDL-cholesterol levels and the prevention of coronary artery disease [1].
价 格:¥电议型 号:T79239产 地:中国大陆
-
T79053PCSK9-IN-17;化合物 PCSK9-IN-17PCSK9-IN-17
PCSK9-IN-17 is a PCSK9 inhibitor utilized in the research of cholesterol metabolism.
价 格:¥电议型 号:T79053产 地:中国大陆
-
T79052PCSK9-IN-16;化合物 PCSK9-IN-16PCSK9-IN-16
PCSK9-IN-16, holds potential for research into hypercholesterolemia and other cardiovascular diseases [1].
价 格:¥电议型 号:T79052产 地:中国大陆
-
T79051PCSK9-IN-15;化合物 PCSK9-IN-15PCSK9-IN-15
PCSK9-IN-15 (compound 5) is a potent inhibitor of proprotein convertase subtilisin/kexin 9 (PCSK9, K D <200 nM) that plays a crucial role in cholesterol metabolism by regulating blood levels of low-density lipoprotein cholesterol (LDL-C). This compound is useful for researching cholesterol-lowering therapies and dyslipidemia [1].
价 格:¥电议型 号:T79051产 地:中国大陆
-
T79030PCSK9-IN-14;化合物 PCSK9-IN-14PCSK9-IN-14
PCSK9-IN-14, also known as compound Ia-8, is a potent inhibitor of PCSK9 [1].
价 格:¥电议型 号:T79030产 地:中国大陆
-
T75545PCSK9-IN-9;化合物 PCSK9-IN-9PCSK9-IN-9
PCSK9-IN-9, a natural isocoumarin, inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9), IDOL, and SREBP2 mRNA expression, demonstrating specificity by inhibiting PCSK9 with an IC50 value of 11.9 μM [1].
价 格:¥电议型 号:T75545产 地:中国大陆
-
T75147PCSK9-IN-18;化合物 PCSK9-IN-18PCSK9-IN-18
PCSK9-IN-18 (compound 188) is a potent PCSK9 inhibitor with a K D value of <200 nM [1] .
价 格:¥电议型 号:T75147产 地:中国大陆
-
T74167PCSK9-IN-3;化合物 PCSK9-IN-3PCSK9-IN-3
PCSK9-IN-3 is a next-generation tricyclic peptide inhibitor of PCSK9, characterized by its novel structure, high potency, and oral bioavailability.
价 格:¥电议型 号:T74167产 地:中国大陆
-
T73008PCSK9-IN-13;化合物 PCSK9-IN-13PCSK9-IN-13
PCSK9-IN-13 is a potent inhibitor of PCSK9, effectively preventing the binding of PCSK9 to low-density lipoprotein (LDL) receptors through its mechanism of action. It exhibits this inhibitory activity with an IC 50 value of 537 nM.
价 格:¥电议型 号:T73008产 地:中国大陆
-
T72025PCSK9-IN-10;化合物PCSK9-IN-10PCSK9-IN-10
PCSK9-IN-10, a potent and orally active inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), exhibits a half-maximal inhibitory concentration (IC50) of 6.4 ?M. By enhancing the expression of Low-Density Lipoprotein Receptor (LDLR) protein and reducing PCSK9 expression, PCSK9-IN-10 effectively decreases atherosclerosis progression. This compound holds promise for hyperlipidemia research applications.
价 格:¥电议型 号:T72025产 地:中国大陆
-
T67776PCSK9-IN-11;化合物PCSK9-IN-11PCSK9-IN-11
PCSK9-IN-11 (compound 5r) is a potent PCSK9 inhibitor with oral activity. PCSK9-IN-11 shows inhibitory activity of PCSK9 transcription in HepG2 cells (IC50= 5.7 μM). PCSK9-IN-11 can increase LDL receptor (LDLR) protein level. PCSK9-IN-11 can be used for atherosclerosis research.
价 格:¥电议型 号:T67776产 地:中国大陆
-
T64362AZD0780;化合物AZD0780PCSK9-IN-12|||EX-A6975;PCSK9-IN-12|||EX-A6975
AZD0780 (EX-A6975) exhibits bind affinity for PCSK9 ( Kd <200 nM). AZD0780 has research value in cholesterol metabolism.
价 格:¥电议型 号:T64362产 地:中国大陆
-
T60764PCSK9 modulator-4;化合物 PCSK9 modulator-4PCSK9 modulator-4
PCSK9 modulator-4 (Compound 21) can be used in hyperlipidemia research that is a potent PCSK9 modulator (EC 50 = 0.15 nM). PCSK9 is a lowering low-density lipoprotein cholesterol (LDL-C) target that is recently validated [1].
价 格:¥电议型 号:T60764产 地:中国大陆
-
T60646PCSK9 modulator-3;化合物 PCSK9 modulator-3PCSK9 modulator-3
PCSK9 modulator-3 (Compound 13) is a potent PCSK9 modulator with an EC 50 value of 2.46 nM that has the potential in the hyperlipidemia research. PCSK9 is a recently proved target for lowering low-density lipoprotein cholesterol (LDL-C) [1].
价 格:¥电议型 号:T60646产 地:中国大陆
-
T60541PCSK9 modulator-2;化合物 PCSK9 modulator-2PCSK9 modulator-2
PCSK9 modulator-2 (Compound 1) is a potent PCSK9 modulator (EC 50 = 202 nM) that has the potential to be used in hyperlipidemia research. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a recently validated therapeutic target for lowering low-density lipoprotein cholesterol (LDL-C) [1].
价 格:¥电议型 号:T60541产 地:中国大陆
-
T39685PCSK9 degrader 1;PCSK9 degrader 1PCSK9 degrader 1
PCSK9 degrader 1 is a selective proprotein convertase substilisin-like/kexin type 9 (PCSK9) degrader. PCSK9 degrader 1 does not affect PCSK9 function.
价 格:¥电议型 号:T39685产 地:中国大陆
-
T39528PCSK9-IN-2PCSK9-IN-2PCSK9-IN-2
PCSK9-IN-2 is a newly developed small molecule that effectively inhibits the protein-protein interaction (PPI) between PCSK9 and LDLR. It has been found to have a potent inhibitory activity with an IC50 value of 7.57 μM.
价 格:¥电议型 号:T39528产 地:中国大陆
-
T13813PCSK9 ligand 1;化合物 T13813PCSK9 ligand 1
PCSK9 ligand 1 is a small molecule ligand for proprotein convertase substilisin-like/kexin type 9 (PCSK9) and shows high affinity to PCSK9(Ki of 107 nM).
价 格:¥电议型 号:T13813产 地:中国大陆